Patent Assignment
Reel/Frame 012977/0516
Merger
Recorded: 2002-06-10
Received: 2002-06-14
Pages: 7
Assignor
COR THERAPEUTICS, INC.
Executed: 2002-02-12
Assignee
MILLENNIUM PHARMACEUTICALS, INC.
75 SIDNEY STREET, CAMBRIDGE, MA, 02139, UNITED STATES
Covered Properties
(20)
Floating Stability Device for Offshore Platform
Application:
10/163,315 →
Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor
Application:
10/127,691 →
Benzamides and related inhibitors of factor Xa
Application:
10/126,976 →
Cloning and Characterization of a Human Adenylyl Cyclase
Application:
10/071,223 →
Identification of Bap-1, a protein that binds to integrin and is involved in integrin-mediated signal transduction
Application:
09/991,888 →
P2U2 Receptor Antibodies
Application:
09/947,922 →
Platelet Adp Receptor Inhibitors
Application:
09/920,325 →
Bicyclic sulfonyl amino inhibitors of factor Xa
Application:
09/816,781 →
Isoquinolone Inhibitors of Factor Xa
Application:
09/816,771 →
Oxindole Inhibitors of Factor Xa
Application:
09/816,782 →
Transgenic Mammals Expressing Mutant Gp Iiia
Application:
09/673,302 →
Modulation of integrin-mediated signal transduction
Application:
09/801,089 →
Inhibitors of Factor Xa
Application:
09/794,214 →
Transgenic Animals Having a Modified Glycoprotein V Gene
Application:
09/775,803 →
Platelet Adp Receptor Inhibitors
Application:
09/775,812 →
Bivalent phenylene inhibitors of factor Xa
Application:
09/773,375 →
2-[1H]-Quinolone and 2-[1H]-Quinoxalone Inhibitors of Factor Xa
Application:
09/773,374 →
3,4-dihydro-2H-benzo[1,4]oxazine inhibitors of factor Xa
Application:
09/773,373 →
Benzimidazole inhibitors of factor xa
Application:
09/773,383 →
Benzimidazolone inhibitors of factor Xa
Application:
09/773,372 →